Human Chorionic Gonadotrophin & Trigger

• Status: Unknown status
• Trial end date: 2017-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

In women being treated with medicines to help eggs to grow (called ovulation induction), The investigators wish to know whether adding medicines (called ovulation triggers) that help to release the egg (ovulation) would lead to more women having babies without causing harm compared with not giving them ovulation triggers.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Chorionic Gonadotropin; Citric Acid; Clomiphene; Enclomiphene; Zuclomiphene

Criteria

Inclusion Criteria:

1. Normoprolactinemic and normogonadotropic (WHO class II ovarian dysfunction )

2. Primary infertility with oligomenorrhea (bleeding intervals between 35 days and 6 months) or amenorrhea (bleeding interval more than 6 months)

3. Age 18-40 years

4. Duration of primary infertility more than2 years

5. No history of ovulation induction treatment

6. No history of thyroid disease

7. Normal results on hysterosalpingogram

8. Husband with normal semen analysis

-

Exclusion Criteria:

1. Ovarian cyst

2. Endometrioma

3. Liver disease